Proving the clinical and financial value of SSO

Monday, April 29th, 2019 | 12:00pm - 1:00pm CST

CHRISTUS Health implemented computer workstation single sign-on (SSO) in 19 hospitals to expedite EHR access. They assessed the workflow and financial value of SSO in reducing clinician time at the keyboard logging in. In this webinar Dr. Gellert will review the impressive results of both login duration after their SSO implementation as well as the dollar value of time saved which was calculated for physicians, nurses and ancillary clinicians.


Join the webinar to learn how CHRISTUS was able to:

  • Identify the overall clinical, operational and financial value proposition of workstation single sign on (SSO)
  • Recognize the nature and magnitude of the impact of SSO on clinician login time by comparing pre-SSO to post-SSO implementation times across 6 hospitals evaluated
  • Recognize the qualitative impact of SSO on clinician satisfaction and how SSO is facilitating adoption of other clinical information technology such as digital documentation
  • Evaluate the results of cost effectiveness and return on investment analyses completed on SSO implementation
  • Analyze the methodology utilized to evaluate and quantify the impact of SSO



George Gellert, MD, MPH, MPA, is a physician executive and epidemiologist focused on health information technologies with a track record of formulating and executing innovative, transformative organizational strategy. Most recently, Dr. Gellert served as the Associate Chief Medical Information Officer or CMIO for CHRISTUS Health, an integrated delivery network with 49 hospitals and long-term care facilities and 175 clinics and outpatient centers in six states, Mexico, Chile and Colombia. He was responsible for ensuring superior performance and optimization of clinical information technology and effective health informatics operational support of over 15,000 CHRISTUS physicians and 6000 nurses. Dr. Gellert has served in industry (GlaxoSmithKline, WebMD), NGOs and the non-profit sector (Project HOPE), as well as in government and at the United Nations International Atomic Energy Agency; he is a graduate of McGill, Yale, UCLA and Harvard universities. He is a fellow of the American Board of Preventive Medicine (FABPM). Dr. Gellert has published over 140 articles and letters in the peer review medical literature, book reviews and chapters and presented at over 220 scientific meetings and conferences.